Literature DB >> 7964456

Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes.

L S Wicker1, J A Todd, J B Prins, P L Podolin, R J Renjilian, L B Peterson.   

Abstract

Development of diabetes in NOD mice is polygenic and dependent on both major histocompatibility complex (MHC)-linked and non-MHC-linked insulin-dependent diabetes (Idd) genes. In (F1 x NOD) backcross analyses using the B10.H-2g7 or B6.PL-Thy1a strains as the outcross partner, we previously identified several non-MHC Idd loci, including two located on chromosome 3 (Idd3 and Idd10). In the current study, we report that protection from diabetes is observed in NOD congenic strains having B6.PL-Thy1a- or B10-derived alleles at Idd3 or Idd10. It is important to note that only partial protection is provided by two doses of the resistance allele at either Idd3 or Idd10. However, nearly complete protection from diabetes is achieved when resistance alleles are expressed at both loci. Development of these congenic strains has allowed Idd3 to be localized between Glut2 and D3Mit6, close to the Il2 locus.

Entities:  

Mesh:

Year:  1994        PMID: 7964456      PMCID: PMC2191746          DOI: 10.1084/jem.180.5.1705

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

Review 1.  The NOD mouse as a model of type I diabetes.

Authors:  Y Tochino
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

2.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.

Authors:  M Hattori; J B Buse; R A Jackson; L Glimcher; M E Dorf; M Minami; S Makino; K Moriwaki; H Kuzuya; H Imura
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

4.  First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

Authors:  S Srikanta; O P Ganda; A Rabizadeh; J S Soeldner; G S Eisenbarth
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

5.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

6.  Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.

Authors:  H Nishimoto; H Kikutani; K Yamamura; T Kishimoto
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

7.  Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.

Authors:  M Prochazka; E H Leiter; D V Serreze; D L Coleman
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

8.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

Authors:  B J Miller; M C Appel; J J O'Neil; L S Wicker
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

9.  Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals.

Authors:  S C Bain; J B Prins; C M Hearne; N R Rodrigues; B R Rowe; L E Pritchard; R J Ritchie; J R Hall; D E Undlien; K S Ronningen
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

10.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  41 in total

1.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

Authors:  Jun Yamanouchi; Dan Rainbow; Pau Serra; Sarah Howlett; Kara Hunter; Valerie E S Garner; Andrea Gonzalez-Munoz; Jan Clark; Riitta Veijola; Rose Cubbon; Show-Ling Chen; Raymond Rosa; Anne Marie Cumiskey; David V Serreze; Simon Gregory; Jane Rogers; Paul A Lyons; Barry Healy; Luc J Smink; John A Todd; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

2.  Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.

Authors:  Sue M Liu; David H Lee; Jenna M Sullivan; Denise Chung; Anneli Jäger; Bennett O V Shum; Nora E Sarvetnick; Ana C Anderson; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

3.  Immunosuppression in islet transplantation.

Authors:  Tom Van Belle; Matthias von Herrath
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

4.  A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish.

Authors:  E I Ginns; P St Jean; R A Philibert; M Galdzicka; P Damschroder-Williams; B Thiel; R T Long; L J Ingraham; H Dalwaldi; M A Murray; M Ehlert; S Paul; B G Remortel; A P Patel; M C Anderson; C Shaio; E Lau; I Dymarskaia; B M Martin; B Stubblefield; K M Falls; J P Carulli; T P Keith; C S Fann; L G Lacy; C R Allen; A M Hostetter; R C Elston; N J Schork; J A Egeland; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping.

Authors:  P A Lyons; N Armitage; F Argentina; P Denny; N J Hill; C J Lord; M B Wilusz; L B Peterson; L S Wicker; J A Todd
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

6.  Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress.

Authors:  Clayton E Mathews; Robert T Graser; Rebecca J Bagley; Jason W Caldwell; Renhua Li; Gary A Churchill; David V Serreze; Edward H Leiter
Journal:  Immunogenetics       Date:  2003-09-25       Impact factor: 2.846

7.  Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.

Authors:  Xiaotian Lin; Emma E Hamilton-Williams; Daniel B Rainbow; Kara M Hunter; Yang D Dai; Jocelyn Cheung; Laurence B Peterson; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

8.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

Authors:  Andrew P R Sutherland; Tom Van Belle; Andrea L Wurster; Akira Suto; Monia Michaud; Dorothy Zhang; Michael J Grusby; Matthias von Herrath
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

Authors:  Julie Mangada; Todd Pearson; Michael A Brehm; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; David V Serreze; Aldo A Rossini; Dale L Greiner
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.